论文部分内容阅读
目的探讨左氧氟沙星三联疗法与阿莫西林三联疗法治疗消化性溃疡的临床疗效。方法选取我院收治的消化性溃疡患者124例,将其随机分为两组,治疗组患者采用左氧氟沙星三联疗法,对照组患者采用阿莫西林三联疗法;比较两组患者的临床疗效及不良反应。结果治疗组患者总有效率为90.3%,明显优于对照组患者的83.9%,组间比较差异有统计学意义(P<0.05);治疗组不良反应发生率为8.1%,对照组不良反应发生率为11.3%,两组比较差异无统计学意义(P>0.05)。结论左氧氟沙星三联疗法治疗消化性溃疡的临床疗效明显,具有安全、经济、不良反应少等优点。
Objective To investigate the clinical efficacy of levofloxacin triple therapy and amoxicillin triple therapy in the treatment of peptic ulcer. Methods 124 patients with peptic ulcer admitted to our hospital were randomly divided into two groups. The patients in the treatment group were treated with levofloxacin triple therapy. The patients in the control group were treated with amoxicillin triple therapy. The clinical efficacy and adverse reactions were compared between the two groups. Results The total effective rate of the treatment group was 90.3%, which was significantly better than that of the control group (83.9%). The difference between the two groups was statistically significant (P <0.05). The adverse reaction rate was 8.1% in the treatment group and the adverse reaction in the control group Rate was 11.3%, no significant difference between the two groups (P> 0.05). Conclusion Levofloxacin triple therapy for the treatment of peptic ulcer obvious clinical efficacy, with safety, economy, fewer adverse reactions and so on.